AMD’s AI Advantage May Just Be Getting Started
While the spotlight often shines brightest on Nvidia, another chipmaker has been clawing its way into the conversation and could soon be in a position to steal the show.
That company is Advanced Micro Devices (NASDAQ: AMD), and it’s gearing up to report second-quarter earnings early next month.
With the stock already up 34% this year,
» Read more about: AMD’s AI Advantage May Just Be Getting Started »
Read More
Micron Is Down 42%, Why It Might Be a Screaming Buy?
Micron Technology (NASDAQ: MU) is no stranger to volatility, but its recent price action has been brutal even by semiconductor standards. Since peaking in June of last year, the stock has tumbled 42%. And nearly 30% of that decline happened in just the past month.
So, is this a falling knife or an undervalued gem in the chip sector?
» Read more about: Micron Is Down 42%, Why It Might Be a Screaming Buy? »
Read More
NVIDIA Just Dropped 30%, Why Smart Money Isn’t Worried
NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the past several years. Despite the returns it has delivered to shareholders, the share price is now under significant pressure.
NVDA’s 52-week high was $153.13, but the stock has been hovering over 30% lower in recent weeks, so will NVIDIA be able to return to its 52-week high,
» Read more about: NVIDIA Just Dropped 30%, Why Smart Money Isn’t Worried »
Read More
Dell Crashed 50%, Why Smart Investors Are Buying the Dip
Dell (NYSE:DELL)’s share price has been on a roller coaster ride in recent months, down from a 52-week high just shy of $180.
With shares now about 50% off their trailing 12-month high point, is now the time to buy Dell?
Key Points
- Despite a 50% stock drop,
» Read more about: Dell Crashed 50%, Why Smart Investors Are Buying the Dip »
Read More
How a $300 Mistake Opened a $1 Billion Market
Novo Nordisk, the pharmaceutical giant behind weight-loss blockbusters Ozempic and Wegovy, just let a key patent on semaglutide lapse in Canada because it forgot to pay a routine maintenance fee, the pharmaceutical equivalent of forgetting to renew your car registration.
As a result, generic versions of semaglutide, the active ingredient in both drugs,
» Read more about: How a $300 Mistake Opened a $1 Billion Market »
Read MoreThe Ivy
Will Buffett’s 23-Quarter Streak Start Again?
For more than half a decade, Warren Buffett’s Berkshire Hathaway accumulated the same stock quarter after quarter, 23 straight times, to be exact. Then, without warning, the buying stopped last year.
It wasn’t because Buffett lost faith in the company. In fact, his recent moves suggest he’s been biding his time, waiting for the numbers and the price to line up again.
» Read more about: Will Buffett’s 23-Quarter Streak Start Again? »
Read MoreThe Spotlight
Paul Tudor Jones Just Dropped a Masterclass on How to Invest Now
Every fall, a tight-knit group of investors gathers for a friendly, but fiercely competitive, stock picking challenge. It’s hosted by Paul Tudor Jones, the legendary hedge fund manager. But it isn’t just for a good cause. The top picks from the event, backed by the likes of Bill Ackman and Stan Druckenmiller, would’ve returned 7x your money in just six months.
» Read more about: Paul Tudor Jones Just Dropped a Masterclass on How to Invest Now »
Read MoreThe Daily
Charlotte Flair discusses WWE retirement; reveals future plans
Despite starting her wrestling career late, Charlotte Flair still became one of the biggest WWE superstars of her generation. The Queen recently opened up about her retirement plans and revealed what she sees in her future.
At the age of 39, Flair is still at the prime of her career,
» Read more about: Charlotte Flair discusses WWE retirement; reveals future plans »